scholarly journals Antitumour efficacy of MEK inhibitors in human lung cancer cells and their derivatives with acquired resistance to different tyrosine kinase inhibitors

2011 ◽  
Vol 105 (3) ◽  
pp. 382-392 ◽  
Author(s):  
F Morgillo ◽  
T Cascone ◽  
E D'Aiuto ◽  
E Martinelli ◽  
T Troiani ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Tyrosine Kinase ◽  
Cancer Cells ◽  
Tyrosine Kinase Inhibitors ◽  
Kinase Inhibitors ◽  
Human Lung ◽  
Acquired Resistance ◽  
Human Lung Cancer ◽  
Mek Inhibitors ◽  
Human Lung Cancer Cells

scholarly journals Efficacy of continuous EGFR-inhibition and role of Hedgehog in EGFR acquired resistance in human lung cancer cells with activating mutation of EGFR

Oncotarget ◽  
2017 ◽  
Vol 8 (14) ◽  
pp. 23020-23032 ◽  
Author(s):  
Carminia Maria Della Corte ◽  
Umberto Malapelle ◽  
Elena Vigliar ◽  
Francesco Pepe ◽  
Giancarlo Troncone ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cancer Cells ◽  
Human Lung ◽  
Acquired Resistance ◽  
Lung Cancer Cells ◽  
Human Lung Cancer ◽  
Egfr Inhibition ◽  
Human Lung Cancer Cells ◽  
Activating Mutation

scholarly journals Coexistence of KRAS mutation with mutant but not wild-type EGFR predicts response to tyrosine-kinase inhibitors in human lung cancer

2014 ◽  
Vol 111 (11) ◽  
pp. 2203-2204 ◽  
Author(s):  
A Choughule ◽  
R Sharma ◽  
V Trivedi ◽  
A Thavamani ◽  
V Noronha ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitors ◽  
Kras Mutation ◽  
Kinase Inhibitors ◽  
Human Lung ◽  
Human Lung Cancer ◽  
Wild Type
Sign in / Sign up

Export Citation Format

Share Document